Abstract |
The objective of this study was to determine the association of 5-HT2C ( serotonin 2C receptor) and MDR1 (multidrug resistant protein) genetic polymorphisms and antipsychotic-induced metabolic abnormalities among female patients with DSM IV schizophrenia spectrum disorders. We have previously reported the associations of -759CT 5-HT2C and G2677T and C3435T MDR1 genetic polymorphisms and olanzapine/ risperidone-induced weight gain in a similar sample of patients. Here, we included a total of 101 previously non-medicated female patients treated with olanzapine/ risperidone over a 3-month period. The variables analyzed included fasting glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein and triglyceride levels in blood, blood pressure and waist circumferences. We observed significant association of -759T 5-HT2C genetic variant and greater increase in waist circumference (P=0.03), fasting glucose level (P=0.046) and triglyceride level (P=0.045) in blood after a 3-month period. The 2677T and 3435T MDR1 genetic variants were significantly associated with the greater increase in fasting glucose level in blood when patients were using olanzapine (P<0.001 and P=0.028, respectively). Our data indicate a possible influence of -759CT 5-HT2C and MDR1 G2677T and C3435T MDR1 genetic polymorphisms on the development of metabolic abnormalities among female patients treated with olanzapine/ risperidone.
|
Authors | M R Kuzman, V Medved, N Bozina, J Grubišin, N Jovanovic, J Sertic |
Journal | The pharmacogenomics journal
(Pharmacogenomics J)
Vol. 11
Issue 1
Pg. 35-44
(Feb 2011)
ISSN: 1473-1150 [Electronic] United States |
PMID | 20195292
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ABCB1 protein, human
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antipsychotic Agents
- Blood Glucose
- Receptor, Serotonin, 5-HT2C
- Benzodiazepines
- Risperidone
- Olanzapine
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics, metabolism)
- Adult
- Antipsychotic Agents
(adverse effects, therapeutic use)
- Benzodiazepines
(adverse effects, therapeutic use)
- Blood Glucose
(metabolism)
- Cohort Studies
- Female
- Humans
- Middle Aged
- Olanzapine
- Polymorphism, Genetic
- Receptor, Serotonin, 5-HT2C
(genetics, metabolism)
- Risperidone
(adverse effects, therapeutic use)
- Schizophrenia
(drug therapy, genetics, metabolism)
- Waist Circumference
- Young Adult
|